白云山:分公司获乙肝解毒胶囊和紫花杜鹃胶囊药品补充申请批件

金融界
28 Mar

金融界3月28日消息,近日, 白云山分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药监局签发的《药品补充申请批准通知书》。包括乙肝解毒胶囊和紫花杜鹃胶囊,二者申请变更药品说明书中安全性等内容,紫花杜鹃胶囊说明书还增加【药品上市许可持有人】名称和注册地址。白云山制药总厂于2024年11月25日递交申请,于11月29日获得受理。乙肝解毒胶囊具有清热解毒等功效,用于乙型肝炎相关病症。2023...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10